These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6514142

  • 1. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
    Blurton PA, Broadhurst AM, Cross JA, Ennis C, Wood MD, Wyllie MG.
    Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
    [Abstract] [Full Text] [Related]

  • 2. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.
    Thomas DR, Nelson DR, Johnson AM.
    Psychopharmacology (Berl); 1987 Sep; 93(2):193-200. PubMed ID: 2962217
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
    Manias B, Taylor DA.
    Eur J Pharmacol; 1983 Nov 25; 95(3-4):305-9. PubMed ID: 6653676
    [Abstract] [Full Text] [Related]

  • 4. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J.
    Psychopharmacology (Berl); 1977 Mar 16; 51(3):225-33. PubMed ID: 403537
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the effects of the selective 5-HT uptake inhibitor WY 27587 on 5-HT uptake into platelets and synaptosomes in the rat.
    Billingsley AJ, Brammer NT, Wood MD, Minchin MC.
    Neuropharmacology; 1989 Jan 16; 28(1):33-6. PubMed ID: 2522598
    [Abstract] [Full Text] [Related]

  • 6. Ifoxetine, a compound with atypical effects on serotonin uptake.
    Waldmeier PC, Maître L, Baumann PA, Hauser K, Bischoff S, Bittiger H, Paioni R.
    Eur J Pharmacol; 1986 Oct 14; 130(1-2):1-10. PubMed ID: 2877890
    [Abstract] [Full Text] [Related]

  • 7. Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum.
    Ennis C, Kemp JD, Cox B.
    J Neurochem; 1981 Apr 14; 36(4):1515-20. PubMed ID: 7264648
    [Abstract] [Full Text] [Related]

  • 8. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Raiteri M, Del Carmine R, Bertollini A, Levi G.
    Eur J Pharmacol; 1977 Jan 21; 41(2):133-43. PubMed ID: 832672
    [Abstract] [Full Text] [Related]

  • 9. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
    Hekmatpanah CR, Peroutka SJ.
    Eur J Pharmacol; 1990 Feb 20; 177(1-2):95-8. PubMed ID: 1971219
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I, Mireylees SE, Sugrue MF.
    Br J Pharmacol; 1977 Oct 20; 61(2):307-13. PubMed ID: 922259
    [Abstract] [Full Text] [Related]

  • 13. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H, Tuomisto J, Airaksinen MM, Kari I, Peura P, Pollari L.
    Acta Pharmacol Toxicol (Copenh); 1980 Apr 20; 46(4):299-307. PubMed ID: 7368949
    [Abstract] [Full Text] [Related]

  • 14. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
    Bolden-Watson C, Richelson E.
    Life Sci; 1993 Apr 20; 52(12):1023-9. PubMed ID: 8445992
    [Abstract] [Full Text] [Related]

  • 15. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
    Wells GB, Lopez MC, Tanaka JC.
    Brain Res Bull; 1999 Apr 20; 48(6):641-7. PubMed ID: 10386845
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice.
    Steranka LR, Sanders-Bush E.
    Eur J Pharmacol; 1980 Aug 08; 65(4):439-43. PubMed ID: 7408949
    [Abstract] [Full Text] [Related]

  • 17. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP, Conarty PF, Nichols DE.
    Eur J Pharmacol; 1991 Jul 23; 200(1):9-16. PubMed ID: 1685125
    [Abstract] [Full Text] [Related]

  • 18. p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo.
    Sharp T, Zetterström T, Christmanson L, Ungerstedt U.
    Neurosci Lett; 1986 Dec 23; 72(3):320-4. PubMed ID: 3822235
    [Abstract] [Full Text] [Related]

  • 19. Behavioural and neurochemical proteins of 1-[1-([indol-3-yl] methyl) piperid-4-yl]-3-benzoylurea (Wy 25093) in rodents.
    Diggory GL, Stephens RJ, Dickison SE, Moser P, Wood MD.
    Arch Int Pharmacodyn Ther; 1980 Nov 23; 248(1):86-104. PubMed ID: 6971080
    [Abstract] [Full Text] [Related]

  • 20. Influence of antipsychotics and serotonin antagonists on presynaptic receptors modulating the release of serotonin in synaptosomes of the nucleus accumbens of rats.
    Drescher K, Hetey L.
    Neuropharmacology; 1988 Jan 23; 27(1):31-6. PubMed ID: 2895429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.